BeStock  

Perrigo PRGO

US equityMarket cap rank #2620Drug Manufacturers - Specialty & Generic
$15.94 −$0.10 (-0.62%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $15.94 0.00%
Open$16.00
Prev close$16.04
Day range$15.53 – $16.40
Volume2.18M
Market cap$2.21B
P/E (TTM)–
Dividend yield7.28%

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$988.60M-5.2% YoY
Operating profit$27.20M-70.9% YoY
Net profit-$27.50M-466.7% YoY
Diluted EPS-$0.20-500.0% YoY
Free cash flow$78.70M+164.1% YoY
Operating cash flow$96.20M

Revenue, last 8 quarters

$1.1BDec '24$1.0BMar '25$1.1BJun '25$1.0BSep '25$1.1BDec '25$969.2MMar '26$1.0BJun '26$988.6MSep '26

Net profit, last 8 quarters

$-44.5MDec '24$-6.4MMar '25$-8.4MJun '25$7.5MSep '25$-1.4BDec '25$-398.5MMar '26$74.4MJun '26$-27.5MSep '26

Diluted EPS by quarter

-0.32Dec '24-0.05Mar '25-0.06Jun '250.05Sep '25-10.22Dec '25-2.87Mar '260.53Jun '26-0.20Sep '26

Free cash flow by quarter

$274.9MDec '24$-90.0MMar '25$56.7MJun '25$29.8MSep '25$148.6MDec '25$-127.4MMar '26$68.3MJun '26$78.7MSep '26

Annual revenue

$4.1BFY20$4.1BFY21$4.5BFY22$4.7BFY23$4.4BFY24$4.3BFY25

Profitability & balance sheet

Gross margin32.3%
Operating margin4.5%
Net margin-43.3%
Return on equity-51.4%
Return on assets-20.1%
Return on invested capital-25.6%
Current ratio2.35
Liabilities / assets67.4%
Cash & investments$436.60M
Total debt$3.29B
Net cash (debt)-$2.86B
Free cash flow / sales4.1%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Self Care$612.70M 62.0%
  • Specialty Care$182.40M 18.5%
  • All other$112.70M 11.4%
  • Infant Formula$80.70M 8.2%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $988.60M $1.02B $969.20M $4.25B $1.11B
Total Operating Revenue $988.60M $1.02B $969.20M $4.25B $1.11B
Cost of Revenue $667.80M $708.90M $643.70M $2.76B $747.40M
Gross Profit $320.80M $313.90M $325.50M $1.49B $362.20M
Operating Expense $293.60M $274.90M $291.90M $1.18B $277.80M
Selling and Admin Expenses $271.70M $251.20M $267.30M $1.06B $255.90M
-Selling & Marketing Expense $147.20M $151.20M $152.30M $619.90M $139.40M
-General & Admin Expense $124.50M $100.00M $115.00M $435.90M $116.50M
Research & Development $21.90M $23.70M $24.60M $95.40M $21.80M
Operating Profit $27.20M $39.00M $33.60M $312.80M $84.40M
Net Non-Operating Interest Income (Expense) -$37.90M -$38.40M -$40.80M -$162.50M -$43.30M
Total Other Finance Costs $37.90M – – – –
Other Income (Expense) -$7.50M $105.00M -$401.30M -$1.45B -$1.37B
Special Income (Charges) -$4.10M -$15.50M -$407.30M -$1.44B -$1.37B
-Less:Restructuring and Mergern & Acquisition $0.00 $14.40M $75.10M $71.90M $13.00M
-Less:Write Off $4.10M $1.00M $330.80M $1.36B $1.36B
Other Non-Operating Income (Expenses) -$3.40M $120.50M $6.00M -$13.20M -$1.30M
Pretax Profit -$18.10M $105.40M -$408.50M -$1.30B -$1.33B
Tax -$3.80M $16.90M -$18.70M $104.40M $82.90M
Net Profit -$27.50M $74.40M -$398.50M -$1.43B -$1.42B
Profit from Continuing Operations -$14.30M $88.50M -$389.80M -$1.40B -$1.41B
Net Income from Discontinuous Operations -$13.20M -$14.10M -$8.70M -$23.10M -$3.50M
Net Income to Parent Company -$27.50M $74.50M -$398.60M -$1.43B -$1.42B
Net Income to Common Stockholders -$27.50M $74.50M -$398.60M -$1.43B -$1.42B
Basic EPS -$0.20 $0.54 -$2.87 -$10.29 -$10.22
Diluted EPS -$0.20 $0.53 -$2.87 -$10.29 -$10.22
Dividend Per Share $0.29 $0.29 $0.29 $1.16 $0.29
Non-Operating Interest Expense – $38.40M $40.80M $162.50M $43.30M
-Less:Other Special Charges – $100,000.00 $1.40M – –
Other Operating Expenses – – – $30.50M $100,000.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $7.48B $7.61B $7.98B $8.54B $8.54B
Total Current Assets $2.40B $2.45B $2.71B $2.80B $2.80B
Cash and Cash Equivalents & Short-Term Investments $436.60M $399.70M $357.20M $531.60M $531.60M
-Cash and Cash Equivalents $436.60M $399.70M $357.20M $531.60M $531.60M
Receivables $685.50M $709.90M $697.10M $612.80M $612.80M
-Accounts Receivable $685.50M $709.90M $697.10M $612.80M $612.80M
Inventory $1.01B $1.06B $1.12B $1.15B $1.15B
Other Current Assets $266.10M $277.60M $272.10M $231.40M $231.40M
Total Non-Current Assets $5.08B $5.16B $5.27B $5.74B $5.74B
Net PPE $976.50M $1.01B $1.04B $1.07B $1.07B
-Gross PPE $976.50M $1.01B $1.04B $2.33B $2.33B
Goodwill and Other Intangible Assets $3.83B $3.89B $3.97B $4.41B $4.41B
-Goodwill $1.69B $1.69B $1.70B $2.05B $2.05B
-Other Intangible Assets $2.14B $2.19B $2.26B $2.36B $2.36B
Non-Current Deferred Assets $6.50M $6.30M $4.70M $3.30M $3.30M
Other Non-Current Assets $266.00M $258.40M $260.70M $261.80M $261.80M
Total Liabilities $5.04B $5.09B $5.48B $5.60B $5.60B
Total Current Liabilities $1.02B $1.05B $997.60M $1.01B $1.01B
Payables $427.60M $429.20M $463.40M $495.30M $495.30M
-Accounts Payable $390.50M $400.40M $434.80M $474.50M $474.50M
-Total Tax Payable $37.10M $28.80M $28.60M $20.80M $20.80M
Current Accrued Expenses $507.60M $528.00M $493.90M $454.20M $454.20M
Short-Term Debt and Capital Lease Obligation $11.30M $11.40M $11.40M $36.60M $36.60M
-Current Debt $11.30M $11.40M $11.40M $36.60M $36.60M
Other Current Liabilities $73.90M $86.20M $28.90M $26.80M $26.80M
Total Non-Current Liabilities $4.02B $4.04B $4.49B $4.59B $4.59B
Long Term Debt and Capital Lease Obligation $3.28B $3.28B $3.62B $3.60B $3.60B
-Long Term Debt $3.28B $3.28B $3.62B $3.60B $3.60B
Derivative Product Liabilities $134.40M – – – –
Non-Current Deferred Liabilities $141.30M $146.70M $153.50M $168.90M $168.90M
Other Non-Current Liabilities $465.60M $608.80M $712.30M $814.30M $814.30M
Total Equity $2.44B $2.52B $2.50B $2.94B $2.94B
Stockholders' Equity $2.44B $2.52B $2.50B $2.94B $2.94B
Capital Stock $6.51B $6.54B $6.58B $6.61B $6.61B
-Common Stock $6.51B $6.54B $6.58B $6.61B $6.61B
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Retained Earnings -$4.03B -$4.00B -$4.08B -$3.68B -$3.68B
Gains/Losses Not Affecting Retained Earnings -$39.30M -$22.80M -$3.00M $4.80M $4.80M
-Accumulated Depreciation – – – -$1.26B -$1.26B

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $96.20M $82.60M -$113.60M $238.50M $175.40M
Net cash flow from continuing operations $96.30M $82.60M -$113.80M $238.50M $175.40M
Net Income from Continuing Operations -$27.50M $74.50M -$398.60M -$1.43B -$1.42B
Gain/Loss from Continuing Operations $0.00 – – $1.60M $0.00
Depreciation & Depletion & Amortization $81.80M $95.80M $83.30M $337.50M $85.90M
Deferred Tax $0.00 -$6.40M -$12.90M -$50.80M -$36.80M
Other Non-Cash Items $5.60M $9.90M $70.60M $82.80M $19.60M
Change in Working Capital $39.20M $35.90M -$196.30M -$101.10M $158.80M
-Change in Receivables $18.80M -$9.80M -$92.50M $30.70M $26.10M
-Change in Inventory $42.20M $50.60M $23.60M -$61.10M $82.60M
-Change in Prepaid Assets $42.70M -$8.70M -$45.90M $8.40M -$5.20M
-Change in Payables and Accrued Expense -$57.60M $3.90M -$84.20M -$78.90M $66.80M
-Change in Other Current Liabilities -$6.90M -$100,000.00 $2.70M -$200,000.00 -$11.50M
Net cash flow from investing -$13.60M $349.40M -$12.40M -$75.40M -$24.50M
Net Cash Flow from Continuing Investing Activities -$13.60M $349.40M -$12.40M -$75.40M -$24.50M
Net PPE Purchase and Sale -$17.50M -$14.30M -$13.80M -$93.40M -$26.80M
Net Business Purchase and Sale $3.40M – – $14.40M $0.00
Net Other Investing Changes $500,000.00 – – -$2.00M -$3.30M
Financing Cash Flow -$43.50M -$388.90M -$45.30M -$220.50M -$54.40M
Net Cash Flow from Continuing Financing Activities -$43.60M -$388.80M -$45.40M -$220.50M -$54.40M
Net Issuance Payments Of Debt -$2.50M $92.60M -$424.30M -$34.80M -$8.70M
Cash Dividends Paid -$40.20M -$40.20M -$39.90M -$159.30M -$39.90M
Net Other Financing Charges -$800,000.00 -$441.30M $418.90M -$26.40M -$5.80M
Ending Cash Balance $436.60M $399.70M $357.20M $531.60M $531.60M
Net Change in Cash $39.00M $43.20M -$171.30M -$57.40M $96.50M
Beginning Cash Balance $399.70M $357.20M $2.30M $558.80M $432.10M
Effect of Exchange Rate Changes -$2.10M -$3.00M -$3.10M $32.50M $3.00M
Free Cash Flow $78.70M $68.30M -$127.40M $145.10M $148.60M
Net Intangibles Purchase and Sale – – $1.40M $5.60M $2.40M
Net Investment Purchase and Sale – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on PRGO.

Sign in to join the discussion.

Scroll to Top